3D MEDICINES: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
3D MEDICINES: INSIDE INFORMATIONCHANGE IN USE OF PROCEEDS FROM 2023 PLACING
3D MEDICINES: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
3D MEDICINES: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
3D MEDICINES: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
3D MEDICINES: Interim Report 2024
3D MEDICINES: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
3D MEDICINES: VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY DIRECTOR AND SINGLE LARGEST SHAREHOLDER AND SENIOR MANAGEMENT
3D MEDICINES: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE 2023 ANNUAL REPORT
3D MEDICINES: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024
3D MEDICINES: DATE OF BOARD MEETING
3D MEDICINES: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
3D MEDICINES: ADOPTION OF CHINESE NAMEAND CHANGE OF STOCK SHORT NAME
3D MEDICINES: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
3D MEDICINES: Amended and Restated Memorandum and Articles of Association
3D MEDICINES: Amended and Restated Memorandum and Articles of Association
3D MEDICINES: POLL RESULTS OF THE ANNUAL GENERAL MEETINGHELD ON JUNE 28, 2024
3D MEDICINES: Form of proxy for the Annual General Meeting to be held on Friday, June 28, 2024
3D MEDICINES: NOTICE OF ANNUAL GENERAL MEETING
3D MEDICINES: GENERAL MANDATES TO ISSUE SHARES ANDREPURCHASE SHARES;RE-ELECTION OF RETIRING DIRECTORS;CHANGE OF AUDITOR;PROPOSED ADOPTION OF CHINESE NAME;PROPOSED AMENDMENTS TOTHE MEMORANDUM ANDARTICLES OF ASSOCIATION OF THE COMPANY;ANDNOTICE OF ANNUAL GENERAL
No Data